Brooks Laboratorie informs about updates

22 Aug 2022 Evaluate
Brooks Laboratorie has informed that it enclosed update under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements, 2015) regarding approval for Meropenem Injection 500mg per via land 1 gram per vial (the product) from the United States Food & Drug Administration (USFDA).

The above information is a part of company’s filings submitted to BSE.

Brooks Laboratories Share Price

140.70 -1.15 (-0.81%)
17-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1751.05
Dr. Reddys Lab 1163.70
Cipla 1515.45
Lupin 1936.75
Zydus Lifesciences 831.40
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...